In a transgenic mouse model of Parkinson's disease, Drp1 function alterations and mitochondrial morphological changes are correlated with ɑ-synuclein-associated pathology; it is also suggested that Drp1 loss-of-function in the mitochondria can lead to enlargement of neuronal mitochondria [29]. The gene discussed is DNM1L; the disease is Parkinson disease.